Viewing Study NCT07037758


Ignite Creation Date: 2025-12-25 @ 12:04 AM
Ignite Modification Date: 2025-12-25 @ 10:03 PM
Study NCT ID: NCT07037758
Status: RECRUITING
Last Update Posted: 2025-12-05
First Post: 2025-06-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)
Sponsor: Amgen
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module